Literature DB >> 23336979

Precision-cut liver slices: a tool to model the liver ex vivo.

Peter Olinga1, Detlef Schuppan.   

Abstract

Mesh：

Year:  2013        PMID： 23336979     DOI： 10.1016/j.jhep.2013.01.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  35 in total

Review 1.  In vitro platforms for evaluating liver toxicity.

Authors:  Shyam Sundhar Bale; Lawrence Vernetti; Nina Senutovitch; Rohit Jindal; Manjunath Hegde; Albert Gough; William J McCarty; Ahmet Bakan; Abhinav Bhushan; Tong Ying Shun; Inna Golberg; Richard DeBiasio; Berk Osman Usta; D Lansing Taylor; Martin L Yarmush
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-24

2.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

Review 3.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

4.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

5.  Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis.

Authors:  Theerut Luangmonkong; Su Suriguga; Emilia Bigaeva; Miriam Boersema; Dorenda Oosterhuis; Koert P de Jong; Detlef Schuppan; Henricus A M Mutsaers; Peter Olinga
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

6.  Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system.

Authors:  A Dash; R A Figler; B R Blackman; S Marukian; M S Collado; M J Lawson; S A Hoang; A J Mackey; D Manka; B K Cole; R E Feaver; A J Sanyal; B R Wamhoff
Journal:  Toxicol In Vitro       Date:  2016-12-07       Impact factor: 3.500

Review 7.  New approaches for fibrosis regression in alcoholic cirrhosis.

Authors:  Wajahat Mehal; Uyen To
Journal:  Hepatol Int       Date:  2016-07-26       Impact factor: 6.047

Review 8.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

9.  Metabolism of Diazinon in Rainbow Trout Liver Slices.

Authors:  Mark A Tapper; Jose A Serrano; Patricia K Schmieder; Dean E Hammermeister; Richard C Kolanczyk
Journal:  Appl In Vitro Toxicol       Date:  2018-03-01

10.  Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Authors:  Jason D Coombes; Steve S Choi; Marzena Swiderska-Syn; Paul Manka; Danielle T Reid; Elena Palma; Marco A Briones-Orta; Guanhua Xie; Rasha Younis; Naoto Kitamura; Marco Della Peruta; Shanna Bitencourt; Laurent Dollé; Ye Htun Oo; Zhiyong Mi; Paul C Kuo; Roger Williams; Shilpa Chokshi; Ali Canbay; Lee C Claridge; Bertus Eksteen; Anna Mae Diehl; Wing-Kin Syn
Journal:  Biochim Biophys Acta       Date:  2015-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.